# Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial

> **NCT03327155** · PHASE3 · COMPLETED · sponsor: **Kirby Institute** · enrollment: 900 (actual)

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** Tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC)

## Key facts

- **NCT ID:** NCT03327155
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-16
- **Primary completion:** 2019-04-30
- **Final completion:** 2020-07-20
- **Target enrollment:** 900 (ACTUAL)
- **Last updated:** 2020-09-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03327155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03327155, "Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03327155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*